ZyVersa Therapeutics’ CEO, Stephen C. Glover, Featured on Benzinga All Access
10 janv. 2024 08h06 HE
|
ZyVersa Therapeutics
View ZyVersa Therapeutics' Benzinga All Access Interview To Learn About Key Development Milestones in 2024.
ZyVersa Therapeutics CEO, Stephen C. Glover, Issues Letter to Shareholders Providing Outlook for 2024
03 janv. 2024 08h07 HE
|
ZyVersa Therapeutics
WESTON, Fla., Jan. 03, 2024 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for...
Unicycive Therapeutics Announces Enrollment of First Patient in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) in Patients with Chronic Kidney Disease on Dialysis
18 déc. 2023 07h03 HE
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
Healthmap Solutions Signs Health Equity Pledge
06 déc. 2023 08h00 HE
|
Healthmap Solutions
Kidney population health management company Healthmap Solutions, Inc. signs Health Evolution Forum’s Health Equity Pledge.
American Kidney Fund Hosts Fourth National Summit on Unknown Causes of Kidney Disease
05 déc. 2023 08h34 HE
|
American Kidney Fund
ROCKVILLE, Md., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) will convene more than 100 medical leaders, patient advocates and academic and industry leaders for the fourth...
American Kidney Fund Renews Calls for Early Diagnosis and Treatment of Chronic Kidney Disease in New Report
30 nov. 2023 09h23 HE
|
American Kidney Fund
ROCKVILLE, Md., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Today the American Kidney Fund (AKF) released a new report that urges policymakers and advocates to broadly support measures—including improved...
Unicycive Therapeutics to Participate in Two Investor Conferences in December 2023
29 nov. 2023 07h03 HE
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the “Company” or “Unicycive”), a clinical-stage biotechnology company developing therapies for...
Africa Healthcare Network (AHN) Secures $20 Million in funding led by Africa50 and AfricInvest for a continent-wide expansion
22 nov. 2023 06h30 HE
|
Africa Healthcare Network
Africa Healthcare Network (AHN), a leading provider of dialysis services in Africa, has secured $20 million in equity and debt funding.
ACADEMY OF NUTRITION AND DIETETICS URGES CONGRESS: PASS BILL TO INCREASE ACCESS TO NUTRITION CARE
15 nov. 2023 09h00 HE
|
Academy of Nutrition and Dietetics
Chicago, Nov. 15, 2023 (GLOBE NEWSWIRE) -- The Academy of Nutrition and Dietetics supports and advocates for expanded access to medical nutrition therapy and additional coverage for more chronic...
William Moore Joins Healthmap as Chief Information Officer
15 nov. 2023 08h00 HE
|
Healthmap Solutions
Healthmap Solutions has named William Moore as Chief Information Officer to oversee expansion of the company’s IT capabilities in kidney care management.